Vimarsana
Biggest News Aggregation in the World

Page 2 - Ophthalmic Solution News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ophthalmic Solution. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ophthalmic Solution Today - Breaking & Trending Today

Analysis Supports Role of Lotilaner Ophthalmic Solution for Demodex Blepharitis - Vimarsana News

Analysis Supports Role of Lotilaner Ophthalmic Solution for Demodex Blepharitis

In a systematic review and meta-analysis of available data, lotilaner ophthalmic solutions outperformed placebo, with few side effects, in treating Demodex blepharitis.

Banned Drugs | Drugs Banned in India | List of Banned Drugs - Vimarsana News

Banned Drugs | Drugs Banned in India | List of Banned Drugs

Several drugs are either banned or withdrawn after introduction in the market.

Strong Initial Nifty, Sensex Rally Meet with Selling - Weekly Closing Report - Vimarsana News

Strong Initial Nifty, Sensex Rally Meet with Selling - Weekly Closing Report

As the final market day of FY23-24 concluded, Indian markets experienced one of their best years, with the Nifty ranking among the top-performing markets in Asia, yielding nearly 29% USD return (second only to Japan). Conversely, China and Hong Kong faced significant underperformance.

Lupin hit 52-week high on USFDA approval for cataract drug - Vimarsana News

Lupin hit 52-week high on USFDA approval for cataract drug

The company's board will meet later in the day to consider and take on record the unaudited standalone and consolidated results of the company for the quarter and nine-months ended December 31, 2023

Lupin receives FDA nod for generic Inderal LA, launches 2 generics - Vimarsana News

Lupin receives FDA nod for generic Inderal LA, launches 2 generics

Lupin has received the FDA's nod for generic Inderal LA ER Capsules, and the company has introduced generic Chantix and generic Prolensa.